US20080096818A1 - Prevention and treatment of amyloidogenic disease - Google Patents

Prevention and treatment of amyloidogenic disease Download PDF

Info

Publication number
US20080096818A1
US20080096818A1 US11/842,085 US84208507A US2008096818A1 US 20080096818 A1 US20080096818 A1 US 20080096818A1 US 84208507 A US84208507 A US 84208507A US 2008096818 A1 US2008096818 A1 US 2008096818A1
Authority
US
United States
Prior art keywords
antibody
an1792
antibodies
pbs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/842,085
Inventor
Dale Schenk
Nicki Vasquez
Theodore Yednock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Sciences Ireland UC
Original Assignee
Elan Pharma International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US6774097P priority Critical
Priority to US8097098P priority
Priority to US09/201,430 priority patent/US6787523B1/en
Priority to US09/322,289 priority patent/US7964192B1/en
Priority to US58001900A priority
Priority to US09/724,102 priority patent/US6787139B1/en
Priority to US09/723,765 priority patent/US7588766B1/en
Priority to US10/933,559 priority patent/US6972127B2/en
Priority to US11/245,916 priority patent/US20060029611A1/en
Priority to US11/842,085 priority patent/US20080096818A1/en
Application filed by Elan Pharma International Ltd filed Critical Elan Pharma International Ltd
Publication of US20080096818A1 publication Critical patent/US20080096818A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26748211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20080096818(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Assigned to ELAN PHARMACEUTICALS, INC. reassignment ELAN PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SCHENK, DALE B., VASQUEZ, NICKI, YEDNOCK, THEODORE
Assigned to NEURALAB LIMITED reassignment NEURALAB LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ELAN PHARMACEUTICALS, INC.
Assigned to ELAN PHARMA INTERNATIONAL LIMITED reassignment ELAN PHARMA INTERNATIONAL LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NEURALAB LIMITED
Assigned to CRIMAGUA LIMITED reassignment CRIMAGUA LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ELAN PHARMA INTERNATIONAL LIMITED
Assigned to JANSSEN ALZHEIMER IMMUNOTHERAPY reassignment JANSSEN ALZHEIMER IMMUNOTHERAPY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CRIMAGUA LIMITED
Application status is Abandoned legal-status Critical

Links